Your browser doesn't support javascript.
loading
Frontal edema due to mesotherapy for androgenetic alopecia: A case series.
Melo, Daniel Fernandes; Saceda-Corralo, David; Tosti, Antonella; Weffort, Flavia; Carla Jorge, Machado; de Barros, Claudia Carreira; de Melo Carvalho, Raquel; Starace, Michela.
Afiliação
  • Melo DF; Department of Dermatology, State University of Rio de Janeiro (UERJ), Rio de Janeiro, Brazil.
  • Saceda-Corralo D; Servicio de Dermatología, Hospital Universitario Ramón y Cajal, Departamento de Medicina, Facultad de Medicina, Universidad de Alcalá, IRYCIS, Madrid, Spain.
  • Tosti A; Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, School of Medicine, University of Miami, Miami, Florida, USA.
  • Weffort F; Department of Dermatology, State University of Rio de Janeiro (UERJ), Rio de Janeiro, Brazil.
  • Carla Jorge M; Department of Preventive and Social Medicine, Federal University of Minas Gerais (UFMG), Belo Horizonte, Brazil.
  • de Barros CC; Department of Dermatology, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil.
  • de Melo Carvalho R; Department of Dermatology, Santa Casa de Misericórdia of Rio de Janeiro, Rio de Janeiro, Brazil.
  • Starace M; Department of Dermatology, State University of Rio de Janeiro (UERJ), Rio de Janeiro, Brazil.
Dermatol Ther ; 35(2): e15247, 2022 02.
Article em En | MEDLINE | ID: mdl-34877759
ABSTRACT
Androgenetic alopecia (AGA) is the most common form of non-cicatricial alopecia in both genders. Currently approved drugs for the treatment of AGA include topical minoxidil in women and topical minoxidil and oral finasteride in men. Other routes of administration of approved drugs have been proposed to enhance therapeutic results for AGA, including intradermal injections, known as mesotherapy. Mesotherapy-or intradermotherapy-is a non-surgical procedure, consisting of multiple intradermal injections of pharmacological substances diluted in small doses. Although minimally invasive, mesotherapy may be related to mild side effects like burning, erythema and headaches, as a few reports indicate. Among the most serious adverse events, subcutaneous necrosis, scalp abscesses, and angioedema have been described. This multicenter retrospective, descriptive study aims to report 14 cases of frontal edema resulting from mesotherapy for AGA treatment. In our patients, the edema mostly arose in the first two sessions and lasted between 1 and 4 days, with a favorable outcome after a local cold compress. In all our cases of edema, lidocaine was the anesthetic used. Minoxidil and dutasteride might also play a role as causative agents. To the best of our knowledge, this is the largest case series focused on frontal edema after mesotherapy for AGA and gives clinicians helpful information for when performing this technique. Dermatologists should already consider and be conscious of this possible mesotherapy side effect, as it can be remarkably disruptive to affected patients.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mesoterapia Tipo de estudo: Observational_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mesoterapia Tipo de estudo: Observational_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article